Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Liptruzet (ezetimibe and atorvastatin) for the Treatment of Hyperlipidaemia

Drug Name (Brand / Generic)

Liptruzet / ezetimibe and atorvastatin

Developed by

Merck

Product Description

Combination of two lipid-lowering compounds – ezetimibe and atorvastatin

Current Indication

Hyperlipidemia

Market Sector

Anti-cholesterol drug

Development Status

Approved in the US
Expand

Go Top